Oragenics, Inc.
OGEN
$0.59
$0.035.45%
AMEX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -41.85% | -74.89% | -75.07% | -73.81% | -73.44% |
| Gross Profit | 41.85% | 74.89% | 75.06% | 73.77% | 73.37% |
| SG&A Expenses | 8.16% | 4.98% | -1.36% | 5.55% | 18.20% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -11.33% | -48.90% | -51.52% | -50.56% | -49.58% |
| Operating Income | 11.33% | 48.90% | 51.50% | 50.51% | 49.49% |
| Income Before Tax | 5.57% | 45.38% | 47.22% | 49.00% | 48.84% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 6.86% | 45.38% | 47.22% | 49.00% | 48.84% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 6.86% | 45.38% | 47.22% | 49.00% | 48.84% |
| EBIT | 11.33% | 48.90% | 51.50% | 50.51% | 49.49% |
| EBITDA | -- | 83.24% | 70.57% | 60.47% | 49.56% |
| EPS Basic | 82.40% | 92.97% | 88.99% | 85.29% | 79.82% |
| Normalized Basic EPS | 82.34% | 92.97% | 88.99% | 85.29% | 79.82% |
| EPS Diluted | 82.40% | 92.97% | 88.99% | 85.29% | 79.82% |
| Normalized Diluted EPS | 82.34% | 92.97% | 88.99% | 85.29% | 79.82% |
| Average Basic Shares Outstanding | 517.98% | 524.62% | 414.87% | 371.62% | 285.44% |
| Average Diluted Shares Outstanding | 517.98% | 524.62% | 414.87% | 371.62% | 285.44% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |